Journal Lancet: Vaccine and Response

journal lancet: Such early trials are designed to evaluate safety and see what kind of immune response was provoked, but can't tell if the vaccine truly protects, according to CTV. In research published Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55 that lasted at least two months after they were immunized. British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine. Newsletter sign-up Get The COVID-19 Brief sent to your inbox We are seeing good immune response in almost everybody, said Dr. What this vaccine does particularly well is trigger both arms of the immune system, he said. Adrian Hill, director of the Jenner Institute at Oxford University. (www.immigrantscanada.com). As reported in the news.